Dr. Mark Kushnir is one of two recipients of the 2021 Al Yergey MS Scientist Award. He is the Scientific Director for Mass Spectrometry Research and Development at the ARUP Institute for Clinical and Experimental Pathology. He spearheaded the adoption of tandem mass spectrometry by ARUP Laboratories and has done exemplary work on developing mass-spectrometry-based clinical assays to be used for patient care, including using desalting columns to purify unbound molecules from plasma samples, leading to a clinical assay for 25-hydroxyvitamin D. He has published more than
100 papers and also been involved with discovery projects and scientific collaborations with many researchers.
Dr. Kushnir has mentored countless people, including R&D colleagues, clinical chemistry fellows and pathology residents. He is an editorial Board Member for many publications and is a regular reviewer for clinical chemistry and analytical chemistry journals and organizations.